I've always put RVVTF and RLFTF in the same category. Both are foreign entities (foreign to the FDA), both are tiny bitechs, neither has revenues, and both claimed to have a near-cure for COVID. So now here they are. Both are hovering between 2 and 3 cents a share. One recently had a devastating R/S, and I predict the other will have one on the near horizon.
MF is the Shroom King with misplaced priorities, and that is brought this company down. JMHO.